Sylvana Research Associates   Report issue

For profit Phase 2
Founded: San Antonio TX United States (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2005
NCT00104377
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Conjunctivitis (Phase 2)

Conjunctivitis, Allergic (Phase 2)

Hypersensitivity (Phase 2)

Hypersensitivity, Immediate (Phase 2)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Rhinitis, Allergic, Seasonal (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4